Preterm lung patient registry for former preterm infants
Part of Lungs & breathing, Women’s health & pregnancy clinical trials.
This registry collects health information from people who were born preterm. It helps doctors better understand lung problems that can occur after preterm birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were born before 37 weeks of pregnancy (a preterm birth)
- You were a preterm infant in the past (not currently pregnant)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a standardized, team-agreed discharge plan to help preterm babies with lung disease (often called BPD) leave the hospital safely. It may help by making the discharge process more consistent, especially for babies going home on breathing support like oxygen.
This study follows the breathing and lung health of very early preterm babies (born before 29 weeks) for two years. It helps doctors understand and improve long-term respiratory care for these tiny infants.
This trial enrolls adults to help build a patient-powered research network for chronic lung disease. If you join, you’ll likely be asked to complete surveys or provide information to help researchers learn how symptoms and health outcomes change over time.
This trial studies a breath test to predict lung disease in very premature babies. It could help doctors start treatment earlier to prevent serious breathing problems.
This study is a European registry that collects medical information (stored electronically) about babies who have retinopathy of prematurity (ROP) severe enough to need treatment. It may help doctors understand outcomes and improve care by tracking real-world results.
This registry is collecting information from pregnant people diagnosed with preterm premature rupture of membranes (PPROM) before 37 weeks. It may help researchers better understand PPROM and improve care for future patients.
Hear when a new Bronchopulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.